RECRO PHARMA INC's ticker is REPH and the CUSIP is 75629F109. A total of 111 filers reported holding RECRO PHARMA INC in Q4 2019. The put-call ratio across all filers is 1.80 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,992,888 | -39.6% | 4,249,229 | +41.7% | 0.03% | -38.1% |
| Q2 2023 | $3,299,152 | -7.6% | 2,999,229 | 0.0% | 0.04% | -16.0% |
| Q1 2023 | $3,569,083 | -16.4% | 2,999,229 | +4.7% | 0.05% | -21.9% |
| Q4 2022 | $4,268,558 | +1642.3% | 2,864,804 | +9449.3% | 0.06% | +700.0% |
| Q1 2020 | $245,000 | -93.3% | 30,000 | -84.9% | 0.01% | -91.8% |
| Q4 2019 | $3,648,000 | – | 199,000 | – | 0.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Engine Capital Management, LP | 872,494 | $6,195,000 | 3.64% |
| Newtyn Management, LLC | 1,600,000 | $11,360,000 | 2.22% |
| Broadfin Capital, LLC | 2,048,025 | $14,541,000 | 1.91% |
| Balter Liquid Alternatives, LLC | 92,167 | $654,000 | 0.45% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 515,414 | $3,660,000 | 0.29% |
| JT Stratford LLC | 45,367 | $322,000 | 0.21% |
| Opus Point Partners Management, LLC | 11,353 | $81,000 | 0.18% |
| Alyeska Investment Group, L.P. | 964,000 | $6,844,000 | 0.10% |
| KENNEDY CAPITAL MANAGEMENT LLC | 500,625 | $3,554,000 | 0.09% |
| Monarch Partners Asset Management LLC | 55,857 | $397,000 | 0.06% |